Inflammatory signaling: another drug target to improve glycemic control in type 2 diabetes.
Goldstein
Barry J
BJ
Division of Endocrinology, Diabetes & Metabolic Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007249:Inflammation; D012459:Salicylates / Q000627:therapeutic use; D015398:Signal Transduction; D057170:Translational Research, Biomedical / Q000639:trends
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012459:Salicylates